Matthew Vogel, MBA, discusses the emergence of clinical trial prediction markets. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4ivvwnU
Lena K. Makaroun, MD, discusses opportunities for clinicians to address firearm-related risks with their older patients. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hGwgX6
Sarah H. Schmitz, MD, discusses protections for people enrolled in trials of investigational agents for obesity. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4y1G6aM
Benjamin D. Scher, DPhil, discusses opioid litigation and governance systems for spending related funds. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4z6uqVo
Stephen Morrissey retweeted
Taking a look at some recent vaccine recommendations. Some hits, some misses. And a hope for better data to inform these decisions. Free to read link in replies. @NEJM @NEJMClinician
Christopher B. Forrest, MD, PhD, discusses declines in the health of U.S. children and the role of communities in reversing those trends. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4cV6xrg
Dhruv Khullar, MD, MPP, discusses concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4yHRxW8
Elizabeth Kaplan, JD, discusses changes to the USPSTF and the importance of evidence-based recommendations for preventive services. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4xQqWpG
Elizabeth Tobin-Tyler, JD, critiques the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4zPEiDS
Rebecca L. Haffajee, JD, PhD, MPH, discusses the rescheduling of medical marijuana products and its potential effect on research. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4gjJh6O
Eric C. Schneider, MD, discusses the limitations of pay-for-performance programs and alternative options to support quality improvement. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hMFnpN
Jean B. Nachega, MD, PhD, MPH, discusses the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4cnjBFh
Jerry Avorn, MD, discusses the role of litigation in addressing product-related damage to health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4hEvVV7
Arnold S. Monto, MD, discusses the value and feasibility of various methods for evaluating the protection offered by vaccines. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4pvArXT
Yaara Zisman-Ilani, PhD, discusses navigating the uncertainty surrounding medication management in autism care. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4wEIlk3
In a new Audio Interview, Dr. Mark Unruh discusses projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity. Listen here: nej.md/4bxQb6V
Justin Barr, MD, discusses physician leadership in American society and politics over the past 250 years. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4eFK0zX
Stephen Morrissey retweeted
About to give a talk at the Black Caucus of the American Library Association about my forthcoming book Healing the Gun Violence Epidemic.
Stacie B. Dusetzina, PhD, discusses a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4eEqwKD
Stephen Morrissey retweeted
Stacie B. Dusetzina, PhD, discusses a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4eEqwKD https://t.























